"10.1371_journal.pone.0092555","plos one","2014-05-01T00:00:00Z","Alexander V Andriyanov; Erez Koren; Yechezkel Barenholz; S Nahum Goldberg","Laboratory of Membrane and Liposome Research, Department of Biochemistry, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel; Radiology Department, Hadassah Hebrew University Medical Center, Ein Kerem, Jerusalem, Israel and Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America","Conceived and designed the experiments: AVA EK YB SNG. Performed the experiments: AVA EK. Analyzed the data: AVA EK YB SNG. Contributed reagents/materials/analysis tools: AVA EK. Wrote the paper: AVA EK YB SNG.","The authors have read the journals policy and have the following conflicts: Yechezkel Barenholz is one of the inventors on two already expired (March 2010) patents relevant to Doxil: 1. Yechezkel Barenholz and Gilad Haran: Method of Amphipathic Drug Loading in Liposomes by pH Gradient. U.S. Patent No. 5,192,549, March 9, 1993. on Water. U.S. Patent 5,244,574, September 14, 1993 2. Yechezkel Barenholz and Gilad Haran: Liposomes: Efficient Loading and Controlled Release of Amphipathic Molecules. U.S. Patent 5,316,771, May 31, 1994. Yechezkel Barenholz is a stock holder of LipoCure Ltd., which prepared the DOX-NP (a Doxil-like PLD) for research applications, which is distributed by Avanti Polar lipids. S. Nahum Goldberg has unrelated sponsored research and consulting with Angiodynamics and Cosman Company, both of whom produce RF devices for tumor ablation. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","05","Alexander V Andriyanov","AVA",4,TRUE,4,2,4,4,TRUE,TRUE,FALSE,0,NA,FALSE
